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Abstract.  We have previously demonstrated that 
chemically modified thrombin preparations  induce en- 
dothelial cell (EC) adhesion,  spreading  and cytoskele- 
tal reorganization via an Arg-Gly-Asp (RGD) sequence 
and the olv33 integrin.  Native thrombin,  however, did 
not exhibit adhesive properties,  consistent with crystal 
structure analysis,  showing that Gly-Asp residues of 
the RGD epitope are buried within the molecule. We 
have now identified a possible physiological mean of 
converting thrombin to an adhesive protein.  Plasmin, 
the major end product of the fibrinolytic system, con- 
verted thrombin to an adhesive protein for EC in a 
time and dose-dependent manner.  EC adhesion and 
spreading  was also induced by a low molecular weight 
(~3,000 D) cleavage fragment generated upon incuba- 
tion of thrombin with plasmin.  Cell adhesion mediated 
by this fragment was completely inhibited by the syn- 
thetic peptide GRGDSP. Conversion of thrombin to an 
adhesive molecule was significantly enhanced in the 
presence of heparin  or heparan  sulfate, while other 
glycosaminoglycans (GAGs) (e.g., dermatan  sulfate, 
keratan  sulfate, chondroitin  sulfate) had no effect. The 
role of cell surface heparan sulfate in thrombin con- 
version to EC adhesive protein was investigated using 
CHO cell mutants defective in various aspects of GAG 
synthesis.  Incubation of both thrombin and a  subop- 
timal amount of plasmin on the surface of formalde- 
hyde fixed wild-type CHO-KI cells resulted in an 
efficient conversion of thrombin to an adhesive mole- 
cule, as indicated by subsequent induction of EC at- 
tachment.  In contrast,  there was no effect to incuba- 
tion of thrombin and plasmin with fixed CHO mutant 
cells lacking both heparan sulfate and chondroitin  sul- 
fate, or with cells expressing no heparan  sulfate and a 
three-fold increase in chondroitin  sulfate. A  similar 
gain of adhesive properties was obtained upon incuba- 
tion of thrombin and plasmin in contact with native, 
but not heparinase-treated  extracellular matrix  (ECM) 
produced by cultured ECs.  It appears that cell surface 
and ECM-associated heparan  sulfate modulate throm- 
bin adhesive properties through its heparin binding 
site in a manner that enables suboptimal amounts of 
plasmin to expose the RGD domain.  Our results dem- 
onstrate,  for the first time, a  significant modulation of 
thrombin molecule by heparin,  resulting in its conver- 
sion to a potent adhesive protein for ECs.  This con- 
version is most effective in contact with cell surfaces, 
basement membranes and ECM. 
C 
ELL interactions with the extracellular matrix (ECM) * 
play  important  roles  in determining  cellular  mor- 
phology,  growth,  and differentiation  (1,  31). When 
cells adhere to a substratum,  contacts are established mainly 
via members of  the integrin superfamily (37, 48). During this 
process, integrins  become localized on the ventral  surface 
of the cells in focal contacts, providing  a transmembrane 
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link between the ECM and the cytoskeleton cell machinery 
(11, 40). 
The vascular endothelium has emerged as a highly  dy- 
namic environment  maintaining  its integrity by factors that 
mediate  the  attachment  and  growth  of endothelial  cells 
(ECs). The integrity of the vascular endothelium is an essen- 
tial requirement governing the vascular tone and permeabil- 
ity, as well as preventing the vessel wall from platelet deposi- 
tion and thrombus formation (19, 36). Most EC receptors for 
ECM proteins  belong to the integrin  superfamily  recogniz- 
ing an Arg-Gly-Asp (RGD) containing  sequence (1, 31). We 
have previously shown that thrombin,  a serine protease with 
major roles in hemostasis, may function as a matrix adhesive 
protein (4, 5). Thrombin preparations  modified either at the 
proCoagulant or catalytic sites, induced EC adhesion  medi- 
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of thrombin  B-chain)  with  the  ave3 integrin  (4).  Native 
thrombin, however, did not exhibit adhesive properties, con- 
sistent with crystal structure analysis showing that of the 
RGD  sequence in thrombin,  only Arg  187  is surface ex- 
posed (9). 
During tissue repair and wound healing the hemostatic 
plug is dissolved by active fibrinolysis, where plasmin is 
generated to degrade the fibrin mesh, releasing functionally 
intact and active thrombin (8).  The plasminogen activation 
system has been implicated in a variety of physiological and 
pathophysiological events,  such as cell migration, fibrinoly- 
sis, tissue remodeling, inflammation, and tumor metastasis 
(13). The presence of plasminogen in appreciable quantities 
in extracellular fluids and extravascular compartments is a 
prerequisite for generation of plasmin through the concerted 
action of plasminogen activators and their inhibitors (41, 
46). Moreover, cell surface receptors for these activators and 
plasminogen (7, 38), as well as the fibrin clot, may serve to 
localize plasmin formation during pericellular proteolysis 
and fibrinolysis. 
We investigated whether activation of the fibrinolytic sys- 
tem may act on the procoagulant protein thrombin in a man- 
ner that exposes its RGD domain. Our results indicate that 
plasmin converts thrombin to a potent adhesive molecule in 
a process that is significantly enhanced by soluble heparin 
and by heparan sulfate on cell surfaces and in the ECM. 
Materials and Methods 
Materials 
Plasmin was purchased from American Diagnostica Inc. (New York, NY). 
Anti-prothrombin antibodies were obtained from Dakopatts Inc. (Glostrup, 
Denmark) and heparin was from Kabi-Pharmacia (Uppsala, Sweden). Tis- 
sue culture dishes were obtained from Falcon Labware Division,  Becton 
Dickinson & Co. (Oxnard, CA), 4-well plates were from Nunc (Rosklied, 
Denmark) and 96-well plates from Costar Co. (Cambridge, MA). DME (1 g 
glucose/liter or 4.5 g glucose/liter, calf serum, FCS, penicillin,  strepto- 
mycin, and  saline containing 0.05  % trypsin,  0.01 M sodium phosphate, 
and 0.02  % EDTA (STV), were obtained from Biological Industries (Beit 
Haemek, Israel).  Bacterial (flavobacterium heparinum) heparinase I (EC 
4.2.2.7,  IBEX  1011) was kindly provided by Dr. J. Zimmermann  (IBEX 
Technologies, Montreal, Canada). The synthetic hexapeptides (GRGDSP, 
GRGESP) were obtained from Peninsula Laboratories, Inc. (Belmont, CA). 
Cells 
Cloned populations of adult bovine aortic  endothelial cells (ABEC) and 
early passage cultures of bovine corneal endothelial cells were established 
as previously described  (23, 24).  Cells were cultured in DME (1 g glu- 
coselliter)  containing  10% bovine calf serum, penicillin (50 U/ml),  and 
streptomycin (50 t~g/ml)  (GIBCO-BRL, Gaithersburg, MD) at 37"C in 10% 
CO2 humidified incubators.  Partially purified,  brain-derived  bFGF (100 
ng/ml) was added every other day during the phase of active cell growth. 
Cells were dissociated with 0.05% trypsin/0.02% EDTA, 0.01 M sodium 
phosphate (pH 7.4) (STV) solution and subeultured at a split ratio of 1:5. 
ECs  were  characterized  by  indirect  immunoflnorescence  using  rabbit 
anti-human factor VIII antigen (Behringwerke Ag, Mailburg, Germany). 
The CHO parental line (KI) and mutant lines (pgs A-745, pgs D-803, and 
pgs D-677) selected for deficiencies in glycosaminoglycans (GAGs) were 
prepared as described (16, 17). Mutant 745 cells are deficient in xylosyl- 
transferase, which catalyzes the first sugar transfer step in GAG biosynthe- 
sis. The total sulfated GAGs produced by these cells is <5% of the amount 
made by the wild type. Mutant 803 cells produce about 16% of  the sulfated 
GAGs found in wild type cells due to a defect in glycosaminoglycan elonga- 
tion,  with decreased heparan sulfate and somewhat decreased content of 
chondroitin sulfate proteoglycans. Mutant 677 does not make any heparan 
sulfate, but synthesizes threefold more chondroitin sulfate proteoglycans 
compared to the wild type (15-17, 34). These cells were cultured in F12 
medium supplemented with 10% FCS. 
Preparation of  Dishes Coated with ECM 
Bovine corneal  endothelial  cells  were  dissociated  from  stock  cultures 
(2nd-5th passage) with STV and plated into 4-well plates at an initial den- 
sity of 5 ×  104 cells/ml. Cells were maintained as described above, except 
that 5 % dextran T-40 was included in the growth medium. For preparation 
of sulfate-labeled ECM, Na2(35S)O4 was added (40 tzCi/ml) 3 and 7 d after 
seeding the cells and the cultures were incubated with the label with no 
medium change. After the cells reached confluence (6-8 d),  the suben- 
dothelial ECM was exposed by dissolving (3 rain, 22"C) the cell layer with 
a solution containing 0.5% Triton X-100 and 20 mM NI-hOH in PBS, fol- 
lowed by four washes in PBS (4, 25, 50). The ECM remained intact, free 
of cellular debris and firmly attached to the entire area of the tissue culture 
dish.  The presence of nuclei,  cytoskeletal  elements and  serum proteins 
could not be detected in the denuded ECM (25). 
Preparation of  Coated Surfaces 
Thrombin and various modified thrombin preparations were diluted to 10 
#g/ml in PBS containing 0.1% BSA and adsorbed onto the surface of 16-ram 
wells of 4-well plates for 2 h at 4°C. Unbound thrombin was removed and 
the dishes were washed three times with PBS. To determine the amount of 
thrombin adsorbed to the surface of  the dish, thrombin was iodinated as de- 
scribed (3) and the amount of  protein adsorbed to the tissue culture plastic 
determined  by ~/ counting of radioactive  material  solubilized with  1 N 
NaOH. In representative experiments, [~25I]thrombin  was included in the 
incubation medium with plastic, cells or ECM, together  with unlabeled 
thrombin at a final concentration of 10 ttg/ml. The concentration of  plasmin 
was 2 #g/ml when incubated with thrombin alone or 0.2 ~g/ml when in- 
cubated in the presence of CHO cells or ECM.  These measurements re- 
vealed that regardless of the amount of cpm added (up to 1 ×  106 cpm) 
,o1% of the thrombin was bound to both plastic and each of the CHO cell 
types, as compared to ,07 % that was bound to ECM. 
Attachment Assay 
Confluent endothelial cells were dissociated with trypsin-EDTA solution, 
washed once in growth medium, and resuspended in DME containing 0.2 % 
BSA. Cells (1.3 ×  lO  s cells/well) were added to each protein-coated well 
and incubated at 37"C for 2 h. The plates were washed three times with PBS 
and the firmly attached cells were fixed with 3 % paraformaidehyde. Fixed 
cells were rinsed with 0.1 M borate buffer (pH 8.5), stained 00 rain at 22"C) 
with 0.1 ml/well methylene blue (1% in 0.1 M borate buffer, pH 8.5), and 
washed four times in borate buffer. This procedure removed practically all 
noncell-bound dye. Specific cell incorporated methylene blue was dissolved 
with 0.1 N HCI (0.2 ml/well, 40 rain, 37"C) and determined by its absor- 
bance at 600 nm.  Uptake of methylene blue is linearly correlated to the 
number of viable cells (22). 
Results 
Effect of  Plasmin on Thrombin-induced  Endothelial 
Cell Attachment 
Native o~-thrombin does not exhibit adhesive properties al- 
though it possesses an RGDA sequence at residues 187-190 
of thrombin B-chain (5). We have previously demonstrated 
that chemical modification of the molecule gives rise to spe- 
cies of thrombin that are highly adhesive to ECs. This points 
to the possibility that chemical modifications alter the mole- 
cule and expose its RGD domain. We investigated whether 
plasmin, the major enzyme active during fibrinolysis, may 
interact with thrombin in a manner that reveals its RGD do- 
main. For this purpose, soluble thrombin was incubated with 
increasing concentrations of plasmin and then analyzed for 
its ability to promote EC attachment. As shown in Fig. 1 a, 
incubation of thrombin with plasmin (0.2-3.5 #g/ml, 25°C, 
pH 6.5)  followed by coating of plastic surfaces, rendered 
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coating with plasmin alone. When thrombin (10/Lg/ml) was 
first used to coat the plastic surface and then treated with 
plasmin (1 #g/ml, pH 6.5, 25°C), little or no attachment ac- 
tivity was observed (not shown), indicating that only soluble 
thrombin can be modulated by plasmin.  In support of this 
observation are experiments subjecting  [t25I]thrombin  and 
(5  x  105 cpm) to plasmin (2/~g/ml, 2 h, 25°C) followed by 
SDS/PAGE and autoradiography, showing little or no degra- 
dation of immobilized thrombin as compared to low rela- 
tive molecular weight fragments generated in solution (not 
shown). This does not exclude the possibility that a limited 
degradation and/or modulation of the bound thrombin may 
occur. Time course studies showed that a 30-min exposure 
of thrombin to plasmin was sufficient to obtain a maximal at- 
tachment of EC to surface immobilized thrombin (Fig. 1 b). 
In  other  experiments  thrombin  (50  #g/ml)  was  prein- 
cubated (4 h, 25°C) with plasmin (10/zg/ml) and cleavage 
fragments were subjected to gel filtration analysis on FPLC 
Superdex 75 column (Fig. 2 a). Four distinct cleavage prod- 
ucts were obtained and the pooled fractions of each peak 
used to coat the surfaces of 4-well plates. EC adhesion was 
induced by  a  low  relative molecular weight  (~3,000  D) 
cleavage product (peak IV) and was completely inhibited in 
the presence of the synthetic peptide GRGDSP (Fig. 2 b). A 
very low residual attachment activity was induced by cleav- 
age products other than those eluted in pooled fraction IV. 
This background activity was similar to that obtained by na- 
tive thrombin and may be mediated by RGD of other adhe- 
sive proteins, mainly fibronectin, possibly secreted by en- 
dotheliai cells during the attachment assay. In an attempt to 
identify and sequence the RGD-containing fragment, the ac- 
tive peak  (#/~,  Fig.  2  a)  was  subjected to reverse phase 
HPLC (C,s column). Several peptides (5-7, in different ex- 
periments) were obtained and tested for adhesion promoting 
activity. For this purpose the acetonitrile was evaporated and 
the samples lyophilized, with little or no effect on the adhe- 
sion promoting activity. Both the active and inactive peptides 
were subjected to partial sequence analysis. Among the pep- 
tides that were clearly identified was a disulfide-linked pep- 
tide (retention time 40.7 min) immediately adjacent to Arg 
of the  RGD  sequence,  having  Lys,86 followed by GEDP- 
KYGAC in its COOH terminus and Glyzs0 in its NH2 termi- 
nus (Fig. 2 c). The disulfide linkage is between Cyst82 and 
Cyst69). We also identified a peptide (retention time 29.39 
min) starting from Lys223 to Arg232.  From these results we 
concluded that exposure of thrombin to plasmin generated 
a  31-amino  acid  peptide,  containing  the  RGD  sequence 
(Arg,87-Arg221; Fig.  2  c).  This  is  due  to  formation of a 
disulfide bond (Cys191  and Cys219) between two fragments, 
taking  into  account that  a  6-amino  acid peptide  (Lys202- 
Arg20~) is cleaved away (Fig. 2 c). We have thus sequenced 
two peptides  adjacent  to  the  31-amino  acid  fragment of 
thrombin which contains the active RGD. Our results also in- 
dicate that plasmin preferentially cleaves next to lysine186, 
leaving the Argls7 intact. 
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F/gure 1.  Effect of plasmin on thrombin adhesive properties.  (a) 
Dose response. Thrombin (10 #g/ml in 10 mM Tris-HC1, pH 6.5) 
was preincubated for 1 h with increasing concentrations of plasmin 
prior to coating plastic surfaces. ECs (0.5 x  10  ~ cells/well) were 
seeded in medium containing 0.2% BSA and unattached cells re- 
moved after a 2-h incubation at 37°C. The number of attached cells 
was evaluated by methylene blue uptake. (b) Time course. 4-well 
plates were coated with thrombin (10 t~g/ml) that was preincubated 
with 1/~g/ml  plasmin for varying periods of  time, as indicated. Cell 
attachment obtained in the presence of thrombin alone (<0.03 OD) 
was subtracted. EC attachment was then measured as described in 
Materials and Methods. The variation between triplicate determi- 
nations did not exceed +15% of the mean. 
heparin. We have therefore  analyzed the effect  of  heparin and 
other GAGs on plasmin modulation of thrombin, as moni- 
tored by the induction of cell attachment activity. EC attach- 
ment was markedly enhanced when thrombin was pretreated 
with plasmin in the presence of increasing concentrations of 
heparin, reaching a maximal effect at 30/~g/ml heparin (not 
shown). This effect was best demonstrated at a suboptimal 
concentration of plasmin (0.2/~g/ml), capable of inducing a 
low level of EC attachment to thrombin. As shown in Fig. 
3, a marked elevation in the attachment activity of thrombin 
was  also observed following incubation of thrombin with 
plasmin in the presence of heparan sulfate (HS). The effect 
was specific to heparin and HS since other GAGs (e.g., der- 
matan sulfate, keratan sulfate, chondroitin sulfate) had no 
effect on the ability of thrombin to induce EC attachment 
(Fig. 3). 
Effect of GAGs on Plasmin-stimulated 
Thrombin-Induced EC Attachment 
Thrombin possesses highly cationic residues that bind effec- 
tively  to  the  negatively  charged  sulfated  polysaccharide 
Effect of Cell Surface 
Heparan Sulfate on Plasmin-Stimulated 
Thrombin-induced EC Attachment 
We investigated the potential involvement of cell membrane 
Bar-Shavit et al. Conversion  of Thrombin to an Adhesive Protein  1281 30 
-~ ~  20 
10" 
0 
0 
a 
v 
~  iii  IV 
fv_  20  40  60  80  100 
Fraction 
< 
1.0"  b 
0.8" 
0.6 2 
0.4" 
0.2"  I 
0.0 
,.2 
I  II  ill  L 
IV  V 
C 
t 
t  t  t  l  t 
S-$'  l 
220  ~30  240 
t  t 
Figure 2.  Gel  filtration  analysis of thrombin-derived  fragments 
cleaved by plasmin. (a) xuI-e-thrombin (50 #g, 5 x  105 cpm) was 
incubated (4 h, 10 mM Tris-HCl, pH E5) in the absence (--o-) or 
presence (-e-) of 10 #g/ml plasmin. The reaction mixture was then 
subjected to gel filtration analysis on FPLC Superdex 75 column 
(Pharmacia, Uppsala). Fractions (0.4 ml) were collected (1 ml/min) 
and counted in a 3' counter. (b) Attachment  activity of thrombin 
fragments generated by plasmin and separated by gel filtration. 
Peak fractions were pooled and each peak (I, II, III, ~  V) was used 
to coat 4-well plates for measurements of EC attachment in the ab- 
sence (m) and presence (~) of GRGDSP peptide. The variation 
between triplicate determinations did  not exceed +12%  of the 
mean. (c) Amino acid sequence of the RGD-contalning region of 
human thrombin B chain. The residues are aligned with residues 
115 through 245 of bovine chymotrypsin. Individual residues are 
identified by the single-letter code. Plasmin cleavage sites are indi- 
cated by arrows. The disulfide bonds (S-S) are shown above the se- 
quence line. 
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Figure 3. Effect of GAGs on thrombin adhesive properties. Throm- 
bin was treated with a low concentration of plasmin (0.2/~g/rnl) in 
the absence or presence of 100 #g/ml GAGs (Hep, heparin; HS, 
heparan sulfate; DS,  dermatan sulfate; KS, keratan sulfate; CS, 
chondroitin sulfate; HA, Hyaluronic acid) before coating dishes. 
ECs were allowed to attach for 2 h at 37°C and the extent of at- 
tached cells was evaluated by the methylene blue uptake assay. At- 
tachment to dishes coated with the GAGs  and native thrombin alone 
(<0.02 OD) was subtracted. There was no attachment of cells to 
dishes coated with the GAGs alone. The variations between tripli- 
cate determinations did not exceed 4-10%. 
associated proteoglycans in plasmin cleavage of thrombin 
and its  subsequent ability to promote EC attachment.  For 
this purpose we have used CHO cell mutants (15-17, 34), ex- 
pressing specific defects  in various aspects of GAG biosyn- 
thesis.  We compared the abilities  of CHO wild type and mu- 
tant  cells  to  promote  plasmin  mediated  conversion  of 
thrombin to an adhesive molecule, as monitored by the stim- 
ulation of EC attachment. Mutant 745 CHO cells, fail to pro- 
duce all  types of proteoglycans due to a  deficiency in en- 
zymes required  to form the  common tetrasaccharide  that 
links GAG chains to core protein (16, 17). The CHO mutant 
677, synthesizes all GAGs except heparan sulfate due to a de- 
fect in the enzymatic activity required to form the repeating 
disaccharide unit characteristic of heparan sulfate  (15). Ex- 
posure of thrombin to plasmin was carried out by incubation 
on the surface of wild-type and mutant CHO cells. To pre- 
vent  secretion  of  adhesive  proteins  by  the  CHO  cells, 
monolaYers were pretreated with monensin (4), or were fixed 
with 3 % formaldehyde. Under these conditions no secretion 
of cellular adhesive proteins was observed, as indicated by 
the lack of EC adhesion when supernatants of the CHO cells 
were used to coat plastic surfaces.  We co-incubated throm- 
bin and plasmin on the surface of fixed CHO wild-type and 
mutant cells and used the  supernatants  for coating dishes 
prior to monitoring the levels of EC attachment. As can be 
seen in Figs.  4 and 5, a marked enhancement of EC attach- 
merit  was observed following incubation of thrombin and 
plasmin on the wild-type CHO cells, as compared to mini- 
mal levels of cell attachment obtained following a similar in- 
cubation with mutant cells lacking all GAGs or only heparan 
sulfate.  Mutant 677 cells expressing a threefold higher level 
of chondroitin sulfate  than the wild-type cells and mutant 
745 cells failed to promote EC attachment to thrombin (Figs. 
4 and 5). The residual extent of cell adhesion and spreading 
observed following incubation of plasmin and thrombin on 
top of HS-deficient CHO mutants (Fig. 5, b and c) may be 
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Figure 4. Adhesive properties of  thrombin after incubation on wild- 
type and HS-deficient CHO mutant cells. Thrombin (10/~g/ml) and 
plasmin (0.2 izg/ml) were preincubated (1 h, 37°C) on the surface 
of formaldehyde fixed  (3%,  15  min)  monolayers  (0.5  x  106 
cells/well) of either CHO-KI wild-type cells (--t~--) or the cell mu- 
tants 677 (-~) and 745 (-4a-). The preincubation was carded out 
for various periods of time, as indicated. Supernatants were col- 
lected and used for coating the dishes. The values were corrected 
for the attachment obtained in the presence of CHO cells incubated 
with thrombin alone (<0.025 OD). ECs were then allowed to ad- 
here and the extent of attached cells was evaluated. (InseO RGD de- 
pendence of thrombin adhesive properties acquired upon incuba- 
tion with CHO-KI cells. Thrombin (10 t~g/rnl) and plasmin (0.2 
/~g/ml) were preincubated (60 min, 24°C) on fixed CHO-KI cells, 
and then collected and used to coat dishes. EC attachment was 
performed in the presence of 0.3 t~g/ml (=) and  1 /~g/ml (r~) of 
the synthetic peptides GRGSDP and GRGESP. The level of EC at- 
taehrnent was evaluated. The variation between different determi- 
nations did not exceed -I-12% of the mean. 
due to a very limited exposure of the RGD sequence in the 
presence of a suboptimal amount of plasmin (0.2/~g/ml; see 
Fig. 1) alone and residual HS (<5 %) expressed by the mutant 
cells. These results indicate that cell surface-associated HS 
is involved in plasmin-mediated conversion of thrombin to 
an adhesive molecule. In control experiments, [t2SI]plasmin 
(0.2/~g/ml,  184,500 cpm) was incubated (2 h, 25°C) with 
CHO  wild  type  and  mutant  cells  to  investigate whether 
differences in cell attachment can be attributed to a differ- 
ence in plasmin binding to the cells, resulting in a different 
conversion of thrombin to an adhesive protein. 8-10 % of the 
added plasmin was bound to the various CHO cell types and 
to  ECM,  indicating  that the  observed differences in  cell 
adhesion are not due to differences in the amount of available 
plasmin. Likewise, the various CHO cell types did not differ 
in their ability to bind [12~I]thrombin (0.7-1%  of the added 
thrombin). Gel filtration analysis and cell adhesion promot- 
ing activity of thrombin fragments generated during incuba- 
tion on top of wild-type CHO cells in the presence of a 
suboptimal concentration (0.2 #g/ml) of plasmin was similar 
to the pattern obtained upon incubation of thrombin and 
plasmin (2/xg/ml) in solution (not shown). 
The enhanced attachment of EC after incubation of throm- 
bin and plasmin on top of fixed wild-type CHO cells was 
mediated through the RGD domain of thrombin. This was 
shown by the complete inhibition of EC attachment obtained 
when the synthetic peptide GRGDSP (Fig. 4, inset), or anti- 
prothrombin antibodies (not shown) were present. There was 
no effect in the presence of GRGESP peptide (Fig. 4, inset), 
or  nonimmune  serum.  The  extent of EC  attachment  to 
thrombin following its incubation with plasmin in contact 
with CHO wild-type cells was  linearly dependent on the 
number of CHO cells (Fig. 6). It is therefore conceivable that 
cell membrane-associated  HS  is  directly involved in  the 
conversion of thrombin by plasmin to an adhesive protein. 
We, therefore, postulated that cell-associated HS modulates 
thrombin in a manner that renders the molecule more acces- 
sible to cleavage by plasmin. This possibility gains support 
from data (Fig. 7) showing that when thrombin alone was 
preincubated on the surface of fixed CHO cells and then col- 
lected and subjected to cleavage by a suboptimal concentra- 
tion of plasmin, a marked stimulation of EC attachment was 
obtained (Fig. 7 C), similar to the effect  observed when both 
plasmin and thrombin were incubated on the cell monolayers 
(Fig. 7 B). When plasmin, on the other hand, was first prein- 
cubated with CHO cells, no induction of EC attachment to 
immobilized  thrombin  was  obtained  (Fig.  7  D).  These 
results indicate that thrombin has to interact with the cell 
surface for its efficient conversion to an adhesive molecule. 
Anti-prothrombin antibodies efficiently inhibited the adhe- 
sive properties of thrombin induced by plasmin on the sur- 
face of fixed CHO-KI cells (Fig. 7 E). 
Conversion of thrombin to an adhesive molecule was also 
accelerated upon incubation of thrombin and plasmin on top 
of a fixed subendothelial ECM (Fig. 8). Similar to the results 
observed with CHO ceils, exposure of thrombin to a low 
concentration plasmin (0.2/~g/ml) resulted in its conversion 
to an adhesive molecule only in the presence of intact ECM, 
or when thrombin was first incubated with ECM (Fig.  8, 
B-D).  This  accelerated conversion was  mediated by  the 
ECM HS since it was markedly inhibited when the ECM HS 
was first extensively degraded by bacterial heparinase (0.5 
U/ml, 2 h, 37°C) (Fig. 8 F). Use of metabolically sulfate 
(Na235SO+) labeled ECM revealed that "~90%  of the total 
incorporated radioactivity was released by treatment with 
the heparinase enzyme. EC attachment to thrombin follow- 
ing exposure to plasmin on fixed ECM was inhibited in the 
presence of GRGDSP peptide (Fig. 8 G) or anti-thrombin/ 
prothrombin antibodies (not shown). 
Discussion 
Adhesive interactions of ceils with their extracellular envi- 
ronment is a complex process associated with morphological 
alterations, ceil migration,  and formation of focal contact 
structures. These adhesive interactions play a leading role in 
the  progression  of  vascular  thrombosis  and  subsequent 
wound healing. After vascular injury, the fibrin-dependent 
aggregation  of platelets  adherent  to  the  exposed  suben- 
dothelium (6, 36) contributes to the formation of thrombus 
that initially seals the vessel to prevent excessive blood loss. 
Subsequently, a local repair mechanism is initiated, involv- 
ing EC attachment, migration, and proliferation to renew the 
damaged  vessel.  Therefore, to  understand  the  molecular 
events involved in thrombus formation and wound healing, 
it is necessary to delineate structural interactions between 
cells and molecules participating in this process. 
The vascular endothelium forms an active boundary be- 
Bar-Shavit et al.  Conversion  of Thrombin to an Adhesive Protein  1283 0.12 " 
B 
0.10 
0.08 
~  006 
,,o, 6  o.o4 
0,02 
0.00 
0.0  015  110  115  21.0 
Attached  CHO-K[  cells 
O.O.  600 nm 
Figure 6. Effect of CHO-KI cell number on the adhesive property 
of thrombin.  EC attachment to dishes  coated with thrombin (10 
gg/ml) that was first incubated (60 rain) with plasmin (0.2/zg/ml) 
on the surface of increasing  numbers of fixed CHO-KI cells (i.e., 
5  x  103,5  x  104,5  x  105, 106  ,2  x  1063  x  106cells/well). 
Correlation plot between the extent of EC attachment and the num- 
ber of CHO-KI cells  was obtained.  The level of attachment ob- 
tained to native thrombin alone was subtracted.  Each data point is 
a mean of five determinations  and the variation  between different 
determinations  did not exceed  +15% of the mean. 
may be  provided  by  the  thrombus,  from which  it  can be 
released intact and active during fibrinolysis or by transen- 
dothelial passage through gaps formed between adjacent EC 
(20,  33,  53). 
In this report we present data showing that plasmin,  the 
major enzyme generated during fibrinolysis, acts on throm- 
bin in a manner that converts it to a potent adhesive mole- 
cule. This conversion was greatly enhanced in the presence 
of heparin  or heparan  sulfate,  but not by other  species  of 
Figure 5. Attachment of  endothelial  cells to plasmin-treated  throm- 
bin,  preincubated on CHO-K/wild-type and HS-deficient  CHO 
cells.  Thrombin (10/zg/ml) and plasmin (0.2 #g/ml) were prein- 
cubated (60 min, 24°C) on formaldehyde  fixed cells: (a) CHO-KI 
wild type; (b) CHO mutant 745; (c) CHO mutant 677. Supernatants 
were then used to coat dishes and the extent of EC attachment was 
evaluated as compared to; (d) dishes coated with thrombin that was 
preincubated  on fixed CHO-KI cells  in the absence of plasmin. 
Phase contrast micrographs were taken after a  1-h incubation at 
37°C with ECs. Bar,  75 #m. 
tween the circulating blood and underlying tissues.  The in- 
tegrity of the system is an essential requirement for the con- 
trolled vascular tone and permeability and for maintaining 
the non-thrombogenic properties of the EC apical surface. 
Thrombin, the central bioregulatory enzyme in hemostasis, 
may be present within the vascular system, immobilized to 
the  subendothelial  basement  membrane,  active  and  pro- 
tected from inactivation (3). ECM-bound thrombin may thus 
exhibit prolonged and localized functions within the vascular 
system.  An internal  source for thrombin in the vessel wall 
1  O0 
o 
60 
40- 
20 " 
0 
A  B  C  O  E 
Figure 7. Effect of incubation with CHO cells on the induction of 
thrombin adhesive properties by plasmin.  The following modes of 
sequential  incubations  were performed: (A) Thrombin (10 #g/ml) 
incubated  (60 rain,  24°C) with plasmin (0.2/~g/ml)  prior to coat- 
ing; (B) thrombin incubated  with plasmin on formaldehyde  fixed 
CHO-KI cell  monolayers;  (C)  thrombin  preincubated  on  fixed 
CHO-KI cell monolayers and then collected and incubated (60 min, 
24°C) with plasmin;  (D) plasmin preincubated  on CHO-KI cell 
monolayers and then collected and incubated with thrombin; and 
(E) preincubation  similar to B with anti-thrombin/prothrombin an- 
tibodies  (1:100) present during the attachment assay. The number 
of EC attachment to NO2-oL-thrombin  (0.32 OD) was evaluated as 
100%. Each data point is a mean of  six determinations  and the vari- 
ation between different determinations  did not exceed +12% of the 
mean. 
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Figure 8. Effect of fixed ECM on the induction of thrombin adhe- 
sive properties by plasmin. The following  modes of  sequential incu- 
bations  were  performed:  (A)  Thrombin  (10  #g/ml)  incubated 
(250C, 1 h) with plasmin (0.2 #g/ml) before coating; (B) thrombin 
and plasmin incubated as in A, but on formaldehyde fixed ECM; 
(C) thrombin (10 #g/ml) incubated (25°C, 1 h) on fixed ECM. The 
incubation medium was then treated (250C, 1 h) with plasmin be- 
fore coating the tissue culture plastic; (D) plasmin (0.2 #g/rnl) was 
incubated  on  fixed  ECM  followed by  treating  the  incubation 
medium with thrombin and coating the plastic surfaces. (E and F) 
ECM was treated (2 h, 37°C) with bacterial heparinase (E, 0.05 
U/ml; F, 0.5 U/ml), fixed, and incubated (1 h, 25°C) with thrombin 
and plasmin. The incubation medium was then used to coat the 
dishes. (G and H) Plasmin and thrombin incubated on fixed  ECM 
before coating. EC attachment was performed in the presence of 
(G) GRGDSP, or (H) GRGESP peptides (1 #g/ml).  The number 
of EC attached to NO2-c~-thrombin (0.35 OD) was evaluated as 
100%. Each data point is a mean of four determinations and the 
variation between different determinations did not exceed +15 % of 
the mean. 
GAGs. Although heparin interacts with both thrombin and 
its inhibitors, anti-thrombin m  (ATIII), and protease nexin-1 
(PN-1), the acceleration of its inactivation is believed to re- 
sult from interaction of thrombin with the inhibitors alone 
(18, 30). It was therefore suggested that thrombin-heparin in- 
teractions are not significant in terms of affecting thrombin 
functional activities (39). Our data demonstrate, for the first 
time,  the  importance  of  thrombin-heparin  interactions, 
resulting  in  modulation  of  thrombin  in  a  manner  that 
markedly enhances its  conversion by plasmin  to a  potent 
adhesive protein. The role of cell surface heparan sulfate in 
this conversion was investigated using a series of genetically 
mutated CHO cells, expressing various defects in GAG syn- 
thesis. By analyzing the level of EC attachment to thrombin, 
following incubation of  plasmin and thrombin on the surface 
of these mutant cells, we demonstrated that cell-associated 
HS  is directly involved in plasmin-induced conversion of 
thrombin to an adhesive molecule. The possibility, however, 
that cell surface modulation of thrombin may require also in- 
teraction with other cell surface molecules, cannot be ex- 
cluded.  Our results show that thrombin acquires adhesive 
properties only upon incubation with  wild-type CHO-KI 
cells, known to possess both HS and chondroitin-4-sulfate 
on the cell surface. No attachment promoting activity was in- 
duced when thrombin and plasmin were preincubated on the 
surface of CHO cell mutants  lacking both GAGs or only 
heparan sulfate, regardless of the content of chondroitin sul- 
fate. Incubation of thrombin with plasmin and soluble hepa- 
rin or HS was less effective than incubation with wild-type 
CHO ceils. 
HS proteoglycans are a diverse group of macromolecules 
containing at  least one covalently bound  HS  chain,  with 
N- and O-linked sulfate groups. They are widely distributed 
throughout animal tissues associated with cell surfaces and 
basement membranes and are becoming increasingly recog- 
nized as mediators of the binding and function of heparin- 
binding growth factors (e.g., bFGF, VEGF, HB-EGF) (21, 
28, 32, 51, 52), adhesive proteins (e.g., N-CAM, fibronec- 
tin) (12), plasma proteins (e.g., vitronectin) (43), enzymes 
(e.g., LPL) (14,  32, 52), enzyme inhibitors (ATIII, PN-1) 
(18, 52) and viruses (47). The structural diversity of HS is 
particularly suited for generating specific domain structures 
that can be used for biological recognition of specific pro- 
teins. A  specific pentasaccharide domain is critical for the 
interaction between heparin and ATIII (32) and has also been 
identified in HS proteoglycans on the surface of capillary EC 
(29, 35). Fibroblasts produce a different, not yet identified, 
species of cell surface and ECM-associated HS that acceler- 
ate the inhibition of thrombin by PN-1 (18). A bFGF-binding 
sequence has recently been identified in fibroblast HS (49). 
Studies are underway to determine whether a specific type 
of cell surface and ECM heparan sulfate is involved in the 
observed plasmin-mediated conversion of thrombin to an 
adhesive molecule. This conversion provides another exam- 
ple of a localized reaction occurring in contact with the cell 
surface and ECM and which is greatly accelerated by HS and 
heparin-like molecules. Recently, it has been shown that cell 
surface HS, but not other GAGs, is the principal site for bind- 
ing of herpes simplex to cells and for subsequent infection 
of the cells (47). Transfection of CHO cell mutants lacking 
HS with FGF receptor revealed that binding of bFGF to the 
receptor requires the presence of either cell surface heparan 
sulfate or soluble heparin (44, 56). In other cases, the pro- 
tein portion in the extracellular domain of HS proteoglycans 
appears to be involved in direct interactions with other mole- 
cules, such as TGF-/3 (2, 54), acidic FGF receptor (45), and 
hyaluronate (10). 
Plasmin is generated enzymatically from plasminogen by 
a highly regulated mechanism of a widely distributed class 
of serine proteases referred to as plasminogen activators. 
The enhanced kinetics of plasminogen activation by tissue 
type plasminogen activator obtained on fibrin as compared 
to solution, provides an extremely efficient mechanism for 
intravascular thrombolysis. Once formed on the fibrin sur- 
face, plasmin initiates the process of substrate degradation. 
As a consequence of the initial proteolysis, carboxy-terminal 
lysyl residues are generated which provide additional bind- 
ing sites for plasminogen and plasmin (27, 54). Moreover, 
when complexed to fibrin, plasmin is protected from inhibi- 
tion by ot2-plasmin inhibitor (26, 42) that effectively inhibits 
circulating  plasmin.  Fibrin-  or  cell  surface-immobilized 
plasmin may thus actively release thrombin trapped within 
a clot and at the same time may expose the cell adhesion do- 
main of thrombin. 
Gel filtration analysis of cleavage products obtained dur- 
ing incubation of thrombin with plasmin suggests that the 
cell adhesion promoting activity of thrombin may reside in 
a  specific fragment,  about 31-amino acids in size,  which 
contains the RGD sequence. It should be noted that the RGD 
site in thrombin is located next to a unique domain which 
is not present in other serine proteases (9). Exposure of this 
specific domain together with the RGD sequence may elicit 
the entire cell adhesion activity induced by thrombin. 
Thrombin-mediated  acceleration  of cell  adhesion  may 
function in maintaining the integrity of the vessel wall. Ex- 
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of thrombin will hopefully clarify whether such a role is in- 
deed fulfilled  by thrombin.  In conclusion, we present evi- 
dence that under certain  conditions thrombin may acquire 
adhesive properties  and hence be actively engaged in sup- 
porting  EC adhesion. Adoption of this unique function of 
thrombin  is  accelerated  by  heparin  and  HS,  particularly 
when  present  on  the  cell  surface  and  ECM.  Chemical 
modifications of thrombin  revealed  that Lys24o and Lyst69, 
positioned near Argt~, render thrombin accessible to hepa- 
rin (9), suggesting  that these positively charged groups are 
crucial  for the conversion of thrombin to an adhesive pro- 
tein.  Moreover,  it is conceivable that beparin may further 
protect Argls7  from cleavage  by plasmin.  Altogether these 
results ascribe a new physiological significance  to the hepa- 
fin binding  property of thrombin. 
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